Targeting tumor cells expressing p53 with a water-soluble inhibitor of Hdm2.

Molecular Cancer Therapeutics
Jirouta KitagakiA M Weissman

Abstract

The tumor suppressor protein p53 is a potent inducer of apoptosis in transformed cells. Hdm2 is an ubiquitin ligase (E3) that acts as a major regulator of p53 by promoting its ubiquitylation and proteasomal degradation. For this reason, inhibiting the E3 activity of Hdm2 has been proposed as a therapeutic approach for cancers expressing wild-type p53. We previously identified a family of small molecules (HLI98s, 7-nitro-10-aryl-5-deazaflavins) that inhibit the E3 activity of Hdm2, increase cellular p53, and selectively kill transformed cells expressing wild-type p53. However, issues of both potency and solubility in aqueous solution limit the utility of the HLI98s. Here, we report that a highly soluble derivative of the HLI98s, which has a 5-dimethylaminopropylamino side chain but lacks the 10-aryl group (HLI373), has greater potency than the HLI98s in stabilizing Hdm2 and p53, activating p53-dependent transcription, and inducing cell death. Furthermore, we show that HLI373 is effective in inducing apoptosis of several tumor cells lines that are sensitive to DNA-damaging agents. These results suggest that HLI373 could serve as a potential lead for developing cancer therapeutics based on inhibition of the ubiquitin ligase activi...Continue Reading

References

Nov 19, 1993·Cell·W S el-DeiryB Vogelstein
Jun 1, 1996·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·K W Kohn
May 15, 1997·Nature·Y HauptM Oren
May 15, 1997·Nature·M H KubbutatK H Vousden
Jul 22, 1998·Nucleic Acids Research·J MomandJ Niland
Sep 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·Z K YuH Zhang
Sep 29, 1999·Proceedings of the National Academy of Sciences of the United States of America·K L LorickA M Weissman
Mar 18, 2000·The Journal of Biological Chemistry·S FangA M Weissman
May 24, 2000·The Journal of Biological Chemistry·N D MarchenkoU M Moll
Mar 14, 2002·Proceedings of the National Academy of Sciences of the United States of America·Eva BalintKaren H Vousden
Oct 31, 2002·Proceedings of the National Academy of Sciences of the United States of America·Zhihong LaiRobert A Copeland
Feb 4, 2003·Nature Reviews. Cancer·Patrick Chène
Mar 26, 2003·Cell·Roger P LengSamuel Benchimol
Jan 6, 2004·Science·Lyubomir T VassilevEmily A Liu
Mar 17, 2004·Oncogene·Yili YangAllan M Weissman
Apr 23, 2004·Nature·David DornanVishva M Dixit
Jun 18, 2004·Cancer Investigation·Julian Adams, Michael Kauffman
Jun 30, 2004·Cellular and Molecular Life Sciences : CMLS·S Fang, A M Weissman
May 20, 2005·World Journal of Gastroenterology : WJG·Wen-Dong LiZhi-Hua Liu
Oct 18, 2005·Current Opinion in Cell Biology·Ute M MollWolfgang Deppert
Jan 5, 2006·Genes & Development·Susan M MendrysaMary Ellen Perry
Jan 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Bo ChenAllan M Weissman
Mar 25, 2006·Cell Death and Differentiation·A J LevineZ Feng
Jul 18, 2006·Nature Cell Biology·Jun TangXiaolu Yang
Jul 25, 2006·Advances in Cancer Research·Swee Sharp, Paul Workman
Oct 27, 2006·Bioorganic & Medicinal Chemistry·Jennifer M WilsonDavid J Robins
Nov 28, 2006·Trends in Molecular Medicine·Lyubomir T Vassilev
Dec 13, 2006·Cancer Cell·Ingo RingshausenGerard I Evan
Dec 22, 2006·Cell·Carla P MartinsGerard I Evan
Mar 24, 2007·Nature Reviews. Molecular Cell Biology·Karen H Vousden, David P Lane
Aug 7, 2007·Molecular Cell·Virginia AmadorMichele Pagano
Aug 28, 2007·Cell·Yael Aylon, Moshe Oren

❮ Previous
Next ❯

Citations

Jun 2, 2012·Frontiers in Bioscience (Landmark Edition)·Alan W LauWenyi Wei
Mar 1, 2014·Nature Reviews. Drug Discovery·Kian Hoe KhooDavid P Lane
Jun 18, 2014·European Journal of Medicinal Chemistry·Sobhi M GomhaAbdelrahman S Mayhoub
Feb 24, 2011·Expert Opinion on Therapeutic Patents·Antonio MacchiaruloRoberto Pellicciari
Jul 5, 2013·Expert Opinion on Therapeutic Targets·Min ShenQ Ping Dou
Apr 15, 2014·FEBS Letters·Galina Selivanova
Jul 22, 2011·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Shuang-feng ChenLe-Xin Wang
Nov 10, 2009·Seminars in Cancer Biology·Michael P DickensPeter M Fischer
Nov 10, 2009·Seminars in Cancer Biology·Nerea Allende-Vega, Mark K Saville
Nov 3, 2009·Bioorganic & Medicinal Chemistry·Ryo HayashiDaniel H Appella
Oct 20, 2009·European Journal of Pharmacology·Sudharsana Rao AndeSubbareddy Maddika
Nov 29, 2008·Cancer Science·Yili YangAlan O Perantoni
Oct 13, 2012·Medicinal Research Reviews·Weisi Wang, Yongzhou Hu
Sep 9, 2011·Cell Cycle·Maren H StindtKaren H Vousden
Oct 12, 2013·Bioorganic & Medicinal Chemistry·Michael P DickensPeter M Fischer
Oct 27, 2017·International Journal of Molecular Sciences·M Reza SaadatzadehKaren E Pollok
Oct 19, 2017·Cancer Metastasis Reviews·Dong WangWenyi Wei
Oct 2, 2015·Zeitschrift Für Naturforschung. C, a Journal of Biosciences·Mohamed M M HusseinMohamed H Elgamal
Jun 19, 2020·Cancers·Ainsley Mike AntaoSuresh Ramakrishna
Jun 4, 2017·BMC Pharmacology & Toxicology·Jagrati JainBabu L Tekwani
Mar 7, 2020·Signal Transduction and Targeted Therapy·Lu DengPing Wang
Mar 16, 2018·Proceedings of the National Academy of Sciences of the United States of America·Gamze Kuser-AbaliZhi-Min Yuan
Oct 8, 2009·Molecular Cancer Therapeutics·Tohru YamadaTapas K Das Gupta
Apr 17, 2020·Signal Transduction and Targeted Therapy·Lu DengPing Wang
Mar 2, 2021·Frontiers in Oncology·Xiuzhen ZhangPing Wang
Apr 24, 2021·Genes & Development·Alyssa M KleinCarol Prives

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis